Long-Term Follow-Up in Patients With Prostate Cancer After Surgery
NCT03035500 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2500
Last updated 2025-12-15
Summary
This clinical trial studies how well a long-term follow-up works in patients with prostate cancer after surgery. Long-term follow-up data may serve as a resource to help ask clinical questions, describe health-related quality of life and long-term complications related, and facilitate future studies focusing on interventions to improve health status and health-related quality of life in prostate cancer survivors.
Conditions
- Cancer Survivor
- Prostate Carcinoma
Interventions
- OTHER
-
Long-term Follow-up
Undergo long-term follow-up using survivorship care plan
- OTHER
-
Quality-of-Life Assessment
Ancillary studies
- OTHER
-
Questionnaire Administration
Ancillary studies
- OTHER
-
Educational Intervention
Receive health education
- OTHER
-
Laboratory Biomarker Analysis
Correlative studies
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
City of Hope Medical Center
lead OTHER
Principal Investigators
-
Saro Armenian, DO · City of Hope Medical Center
Study Design
- Allocation
- NA
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-07-23
- Primary Completion
- 2026-07-28
- Completion
- 2026-07-28
Countries
- United States
Study Locations
More Related Trials
-
Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer After Undergoing Surgery
NCT01923506 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Study of Blood and Urine Samples in Patients With Newly Diagnosed Localized Prostate Cancer Treated With Hormone Therapy and Radiation Therapy. ICORG 06-15
NCT00955435 ·Status: UNKNOWN
-
Surgery in Treating Patients With Prostate Cancer
NCT00002938 ·Status: COMPLETED ·Phase: PHASE2
-
Identifying the Best Follow up Approach for People Who Have Had Treatment to Cure Newly Diagnosed Prostate Cancer
NCT07264088 ·Status: NOT_YET_RECRUITING
-
A Study of Definitive Therapy to Treat Prostate Cancer
NCT02716974 ·Status: COMPLETED ·Phase: PHASE2
-
Prognostic Factors in Prostate Cancer for Patients Treated by Watchful Waiting
NCT03912883 ·Status: ACTIVE_NOT_RECRUITING
-
A Study of Definitive Therapy to Treat Prostate Cancer After Prostatectomy
NCT03043807 ·Status: COMPLETED ·Phase: PHASE2
-
Hormone Therapy and Intensity-Modulated Radiation Therapy in Treating Patients With Metastatic Prostate Cancer
NCT00544830 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Determining Patterns In Trial Experiences of Recurrent Prostate Cancer Patients
NCT06070272 ·Status: NOT_YET_RECRUITING
-
Early Stage Prostate Cancer Cohort
NCT00011349 ·Status: COMPLETED
-
Quality of Life in Patients Undergoing Surgery or Brachytherapy for Stage II Prostate Cancer
NCT00052481 ·Status: COMPLETED
-
Metastasis-directed Therapy for Oligorecurrent Prostate Cancer
NCT05352178 ·Status: RECRUITING ·Phase: PHASE3
-
Study to Assess Efficacy and Safety of Zoledronic Acid and the Value of Markers of Bone Resorption in the Prediction of Bone Metastases and Cancer Treatment-induced Bone Loss (CTIBL) in Patients With Prostate Cancer on Hormone Therapy
NCT00172055 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Detect Changes in Urinary and Gut Microbiome During Androgen Deprivation Therapy and Radiation Therapy in Patients With Prostate Cancer
NCT04775355 ·Status: RECRUITING
-
PSCA-Targeting CAR-T Cells Plus or Minus Radiation for the Treatment of Patients With PSCA+ Metastatic Castration-Resistant Prostate Cancer
NCT05805371 ·Status: RECRUITING ·Phase: PHASE1
-
Immediate Postoperative Adjuvant Hormonal Treatment in High Risk Localised or Locally Advanced Prostate Cancer Patients.
NCT01123434 ·Status: COMPLETED
-
Longitudinal Assessment of Health-Related Quality of Life in Men With Localized Prostate Cancer
NCT00582842 ·Status: COMPLETED
-
To Live Better After Prostate Cancer Treatment:
NCT05100121 ·Status: RECRUITING ·Phase: NA
-
Study of PSMA-targeted 18F-DCFPyL PET/CT for the Detection of Clinically Significant Prostate Cancer
NCT03471650 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Impact of Hormonal Therapy on Prostate Cancer Recurrence After Radical Prostatectomy
NCT05169112 ·Status: RECRUITING ·Phase: PHASE3
-
A Study to Describe Patterns of Care and Outcomes of Men Who Are at High Risk After Experiencing Biochemical Failure Following Definitive Prostate Cancer Therapy, Men With Castration-resistant Prostate Cancer and Men With Metastatic Prostate Cancer
NCT02066961 ·Status: COMPLETED
-
Molecular Characterization of CTCs and ctDNA in Blood and Plasma Samples From Patients With Metastatic and/or Hormone-Resistant Prostate Cancer
NCT02370355 ·Status: TERMINATED
-
Evaluation of Molecular Forms of PSA and Human Kallikrein 2 in a Cohort of Patients With Locally Resected Prostate Cancer But Biochemical Recurrence
NCT02070575 ·Status: COMPLETED
-
Cytoreductive Prostatectomy Combined With Triple or Dual Systemic Therapy in mHSPC Patients
NCT06350825 ·Status: RECRUITING ·Phase: PHASE3
-
A Study of High Risk Localized Prostate Cancer Participants Treated With Radical Prostatectomy and Perioperative Hormonal Therapy
NCT05303558 ·Status: COMPLETED